Organigram (OGI) to Release Quarterly Earnings on Monday

Organigram (NASDAQ:OGI - Get Free Report) is anticipated to issue its Q2 2025 quarterly earnings data before the market opens on Monday, May 12th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $61.27 million for the quarter.

Organigram (NASDAQ:OGI - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative net margin of 31.69% and a negative return on equity of 8.59%. On average, analysts expect Organigram to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Organigram Price Performance

NASDAQ OGI traded up $0.07 on Friday, hitting $1.18. 670,453 shares of the stock were exchanged, compared to its average volume of 689,603. The business's fifty day moving average is $1.05 and its 200 day moving average is $1.37. Organigram has a 52 week low of $0.85 and a 52 week high of $2.11. The company has a market capitalization of $157.93 million, a PE ratio of -3.11 and a beta of 1.35.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.